Signet’s First PharmaCatalyst Series Concludes with Resounding Success

Signet successfully concluded its inaugural PharmaCatalyst: Empowering Compliance, Enabling Innovation seminar series, held from 14th to 17th July 2025. The pioneering series focused on recent trends and advances in drug delivery systems and drew enthusiastic participation from over 250 key stakeholders across pharmaceutical R&D and allied sectors.

Marking a significant milestone, PharmaCatalyst also represented Signet’s first-ever seminars in Goa, Chennai, and Delhi—each city witnessing strong attendance and active engagement.

Organized in collaboration with our esteemed Principal Partners—Roquette, BASF, Innophos, Eastman, Hanns G. Werner, and DuPont—the series featured insightful presentations on specialty excipients and their advanced applications.

Each session included lively discussions and interactive Q&As, fostering dynamic knowledge exchange between industry experts and formulators. This inaugural PharmaCatalyst series not only empowered participants with compliance-driven formulation insights but also reaffirmed Signet’s commitment to advancing innovation in pharmaceutical development.